Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

被引：0
作者：
Konidaris, V.
Gorgoli, K.
Burgula, S.
Deane, J.
Banerjee, S.
Empeslidis, T.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2016年 / 94卷
关键词：
D O I：
10.1111/j.1755-3768.2016.0316
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[41]   Incremental Cost-Utility Ratio of Intravitreal Aflibercept Compared with Ranibizumab for the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion [J].
Cruess, Alan F. ;
Jeddi, Mark ;
Goeree, Ron ;
Blackhouse, Gord ;
Eriksson, Marianne .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[42]   Branch and central retinal vein occlusion: clinical pearls from trials of ranibizumab [J].
Liu, Mimi ;
Eichenbaum, David ;
Taylor, Sarah ;
Wang, Pin-wen ;
Quezada-Ruiz, Carlos .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[43]   Aflibercept: Newly Approved for the Treatment of Macular Edema Following Central Retinal Vein Occlusion [J].
Evoy, Kirk E. ;
Abel, Steven R. .
ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) :819-827
[44]   Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion [J].
Wibbelsman, Turner D. ;
Calem, Daniel B. ;
Obeid, Anthony ;
Mellen, Phoebe L. ;
Konkoly, Michelle A. ;
Velez, Michael R. ;
Sioufi, Kareem ;
Borkar, Durga S. ;
Pandit, Ravi ;
Klufas, Michael A. ;
Hsu, Jason ;
Regillo, Carl ;
Ho, Allen C. ;
Gupta, Omesh P. ;
Spirn, Marc J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
[45]   A retrospective comparison of aflibercept and ranibizumab in the management of macular oedema secondary to retinal vein occlusion [J].
Di Simplicio, Sandro ;
Hogg, Jeff .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[46]   Intravitreal Ranibizumab Treatment for Macular Edema Associated with Central Retinal Vein Occlusion and Hemiretinal Vein Occlusion: Cases Reports [J].
Matias, Joao ;
Matos, Rita .
OPHTHALMOLOGICA, 2014, 232 :74-75
[47]   12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry [J].
Niedzwiecki, Mateusz ;
Hunt, Adrian ;
Nguyen, Vuong ;
Mehta, Hemal ;
Creuzot-Garcher, Catherine ;
Gabrielle, Pierre-Henry ;
Guillemin, Martin ;
Fraser-Bell, Samantha ;
Arnold, Jennifer ;
McAllister, Ian L. ;
Gillies, Mark ;
Barthelmes, Daniel .
ACTA OPHTHALMOLOGICA, 2022, 100 (04) :E920-E927
[48]   Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naive and refractory macular oedema in branch retinal vein occlusion [J].
Elkazza, Sumeia A. ;
Hogg, H. D. Jeffry ;
Di Simplicio, Sandro ;
Dlay, Satnam S. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) :NP303-NP304
[49]   Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab [J].
Kerr Brogan ;
Monica Precup ;
Amanda Rodger ;
David Young ;
David Francis Gilmour .
BMC Ophthalmology, 18
[50]   Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab [J].
Brogan, Kerr ;
Precup, Monica ;
Rodger, Amanda ;
Young, David ;
Gilmour, David Francis .
BMC OPHTHALMOLOGY, 2018, 18
12345